^®: CRE Regulatory Action of the Week

FDA Again Extends Comment Period for Review of Homeopathic Products Regulation
The U.S. Food and Drug Administration is reconsidering its regulatory framework for homeopathic products after 25 years of regulation. The FDA is reopening the comment period for the notice of public hearing that appeared in the Federal Register of March 27, 2015. FDA is taking this action in response to requests to allow interested persons additional time to submit comments. FDA already extended this comment period once before on June 10, 2015 (80 FR 32868). The deadline for comments is now November 9, 2015.